Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2751–2800 of 18397
On January 10, 2025, David W. Heinzmann notified the Board of Directors (the “Board”) of Littelfuse, Inc. (the “Company”) of his intention to retire as President and Chief Executive Officer of the Company, effective February 10, 2025.
On January 10, 2025, the Board appointed Gregory N. Henderson to succeed Mr. Heinzmann as President and Chief Executive Officer of the Company, effective February 10, 2025.
On January 10, 2025, the Board of Directors (the “Board”) of the Company appointed Romin Nabiey, the Company’s current Chief Accounting Officer, as Interim Chief Financial Officer of the Company, effective as of the Effective Date.
On January 7, 2025, Karsten Voermann submitted his resignation as Chief Financial Officer of GoodRx Holdings, Inc. (the “Company”), effective January 17, 2025 (the “Effective Date”) for personal reasons.
on January 12, 2025, the Board appointed Tom Conrad as Interim CEO and President, effective January 13, 2025.
On January 12, 2025, Patrick Spence and the Board of Directors (the "Board") of Sonos, Inc. (the "Company") agreed that Mr. Spence will step down as Chief Executive Officer ("CEO") and as a member of the Board, effective as of January 13, 2025.
Thomas C. Rice has been appointed as TVA’s new Senior Vice President and Chief Financial Officer, effective January 27, 2025.
John M. Thomas, III, who, on December 2, 2024, announced his retirement from his position with TVA effective March 7, 2025
appointed Matthew Sullivan to serve as Chief Financial Officer of the Company, effective as of January 10, 2025.
the Board and Andrew Clark, the Company’s Chief Financial Officer, mutually agreed that Mr. Clark will resign from his positions as Chief Financial Officer and Vice President of the Company, effective as of the Effective Date.
On January 7, 2025, Jaime Hinojosa informed Astrotech Corporation (the “Company”) of his resignation from the positions of the Company’s Chief Financial Officer, Treasurer and Secretary, effective February 14, 2025.
The Board of Directors of Pulse Biosciences, Inc. (the “Company”) has appointed Paul A. LaViolette, current Co-Chairman of the Board, as Chief Executive Officer and President of the Company, effective as of January 9, 2025
and Mr. Andy F Wong to serve as the Chief Financial Officer of the Company
accepted the resignation of Mr. Shang-Chiai Kung from his positions as Chief Executive Officer and Chief Financial Officer of the Company.
the Board appointed Mr. Tse-Ling Wang to serve as the Chief Executive Officer of the Company
accepted the resignation of Mr. Shang-Chiai Kung from his positions as Chief Executive Officer and Chief Financial Officer of the Company.
the Company and Sergio Cervantes, the Chief Financial Officer of the Company agreed that Mr. Cervantes’ would depart the Company, effective February 16, 2025
On January 6, 2025, the Company appointed Tom Siragusa the Company’s interim Chief Financial Officer effective February 16, 2025
Fillipo “Peter” Caldini, the Company’s current President, will serve as Interim CEO as of March 1, 2025.
Juan José Chacón-Quirós, the Company’s Chief Executive Officer, has provided notice of his decision to retire from his position as Chief Executive Officer, effective on March 1, 2025.
In connection with Mr. Fuentes’ appointment as Chief Financial Officer, Simon Tarsh was removed as Interim Chief Financial Officer of the Company.
Effective January 6, 2025, the board of directors (the “ Board ”) of Renovaro Inc. (the “ Company ” or “ Renovaro ”) appointed Nathen Fuentes, age 42, as Chief Financial Officer of the Company.
the Board of Directors (the “Board”) of the Company appointed Ciaran Long, the Interim Chief Executive Officer of the Company and Chief Financial Officer of the Company (“Chief Financial Officer”), to the position of Chief Executive Officer of the Company and removed him from the position of Chief Financial Officer, in each case effective January 13, 2025.
On January 7, 2025, F. Scott Anthony, Executive Vice President and Chief Financial Officer (principal financial officer) of Coca‐Cola Consolidated, Inc. (the “Company”), notified the Company of his resignation from all of his positions with the Company and its subsidiaries and affiliates, effective March 31, 2025 (the “Effective Date”).
the Executive Committee of the Board of Directors of the Company appointed Matthew J. Blickley, the Company’s Senior Vice President, Financial Planning and Chief Accounting Officer (principal accounting officer) as Executive Vice President and Chief Financial Officer (principal financial officer) of the Company, effective April 1, 2025.
This Amendment is being filed to disclose to correct the effective date of the resignation of Troy Reisner, former Chief Financial Officer of the Company.
On January 6, 2025, the Company appointed Mr. Vu, 41, as permanent Chief Financial Officer (“CFO”) of the Company.
On January 10, 2025, Marchex, Inc. (the “Company”) announced the termination of employment of Holly Aglio (“Aglio”), Chief Financial Officer of the Company, effective as of that date.
Effective on April 1, 2025, Mr. Chao will assume the positions of Chief Financial Officer, Assistant Secretary and Treasurer
Christopher Smith, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), will retire effective April 1, 2025
On January 10, 2025, the Company announced the appointment of Tony Zook to replace Mr. Smith as Chief Executive Officer effective April 1, 2025.
Jesse Arenivas, President, Chief Executive Officer, and a member of the Board of Directors of EnLink Midstream Manager, LLC, the managing member (the “Manager”) of ENLC, will be departing from ENLC
Dr. Srinivas Rao will serve as the Company’s sole Chief Executive Officer and principal executive officer, effective January 1, 2025.
Florian Brand stepped down as Co-Chief Executive Officer and member of the Company’s management board as of December 31, 2024.
Mike Rawls, EVP & Chief Executive Officer of Xome, notified Mr. Cooper Group Inc. (the “Company”) of his intention to retire from his position at the Company effective June 30, 2025.
On January 7, 2025, Tammy Romo, Executive Vice President & Chief Financial Officer of Southwest Airlines Co. (the “Company”), submitted her resignation from the position of Executive Vice President & Chief Financial Officer, effective April 1, 2025.
with Mr. Moss designated as interim Chief Executive Officer and the principal executive officer of the Company.
On January 5, 2025, Mr. Joseph A. Mills informed the Board of Directors (the “Board”) of Talos Energy Inc. (the “Company”) that he was resigning from his position as Interim Chief Executive Officer and President and as a member of the Board, effective immediately.
On January 7, 2025, the Board of Directors of Viridian Therapeutics, Inc. (the “Company”) appointed Seth Harmon to serve as the Chief Financial Officer of the Company effective as of January 1, 2025.
On January 7, 2025, Richard Rosenblum provided written notice to the board of directors (the "Board") of Innovative Payment Solutions, Inc., a Nevada corporation (the "Company"), of his resignation as President, Chief Financial Officer, Secretary, and as a member of the Board, effective immediately.
appointed William D. Corbett, the current Executive Chairman of the Company, to the additional office of Chief Executive Officer of the Company.
William J. Febbo stepped down from his positions as Chief Executive Officer (“CEO”) and Member of the Board of Directors (the “Board”) of OptimizeRx Corporation (the “Company”) effective as of December 31, 2024.
On December 20, 2024, the board of directors of Healthtech Solutions, Inc. (the “Company”) removed Manuel Iglesias as the Company’s President and Chief Financial Officer
On December 1, 2024, the Board of Directors appointed Ms. Patricia Kaelin, CPA, as Chief Financial Officer of the Company.
on December 24, 2025 the Board of Directors of the Company (the “Board”) appointed Arun Jeldi to serve as Chief Executive Officer of the Company.
Effective January 6, 2025, Mr. Xiaowen Zheng, 39 years old, was appointed by the Board of Directors (the “Board”) of the Company to the position of Chief Financial Officer of the Company.
On January 5, 2025, Ms. Tianfeng Li, the Chief Financial Officer of Aixin Life International, Inc. (the “Company”), tendered her resignation as Chief Financial Officer of the Company, effective January 5, 2025.
On January 10, 2025, the Board of Directors of the Company appointed Paul McGarry to serve as Interim Chief Financial Officer of the Company, effective February 1, 2025.
On January 6, 2025, Jesse Deutsch notified American Battery Technology Company (the “Company”) of his intent to retire and step down as Chief Financial Officer, effective January 31, 2025
On January 4, 2025, the Board of Directors (the “Board”) of Lantronix, Inc. (the “Company”) appointed Brent Stringham as the Company’s Chief Financial Officer effective as of January 6, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.